Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micafungin (FK463) for Candidemia or Invasive Candidiasis
NCT00036179Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Feb 1999
- Primary completion
- Jan 2002
- Modality
- Small Molecules
- Countries
- 8
01
Overview
Phase 2, open-label, single-arm trial of micafungin in candidemia and invasive candidiasis, sponsored by Astellas Pharma. Primary endpoints: Safety and Efficacy. Started Feb 1999; status: completed.
02
Drugs
micafungin
03
Conditions
candidemiainvasive candidiasis
Beyond the preview
Go deeper on NCT00036179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00036179.